US Stock MarketDetailed Quotes

IRD Opus Genetics

Watchlist
  • 0.979
  • -0.009-0.87%
Close Dec 20 16:00 ET
  • 1.060
  • +0.081+8.32%
Post 20:01 ET
30.89MMarket Cap-0.90P/E (TTM)

Opus Genetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Opus Genetics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.000M--
--2024/Q4-- / 11.104M--
--2024/Q33.867M / 2.296M--
--2024/Q21.112M / 1.942M--
--2024/Q11.711M / 4.670M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.000M--
--2024/Q4-- / 11.104M--
--2024/Q33.867M / 2.296M--
--2024/Q21.112M / 1.942M--
--2024/Q11.711M / 4.670M--

Unlock Free Earnings Estimates

Opus Genetics Earnings Reports

  • Opus Genetics | 8-K: Opus Genetics Announces Financial Results for Third Quarter 2024 and Provides Corporate Update

    Nov 12 09:42 ET

  • Opus Genetics | 10-Q: Q3 2024 Earnings Report

    Nov 12 09:40 ET

  • Ocuphire Pharma | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:12 ET

  • Ocuphire Pharma | 8-K: Ocuphire Pharma Announces Financial Results for Second Quarter 2024 and Provides Corporate Update

    Aug 13 08:17 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Ermenegildo Zegna NV
    ZGN
    +6.16%
    DexCom
    DXCM
    +5.57%
    New Fortress Energy
    NFE
    +5.37%
    Workday
    WDAY
    +2.33%
    eBay
    EBAY
    +1.66%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 15, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data